Shaw's Eco-Logic

Another year, another drug kickback settlement. This HND piece covers the qui tam action which resulted in a $39 million settlement against Daiichi Sankyo. In this particular matter, the defendant violated both the False Claims Act and the Anti-Kickback Act.

The drugs in question are Welchol (cholesterol-lowering); and Benicar, Azor, and Tribenzor (antihypertensives).

Yes, the company got dinged, but what about the bribed doctors? Read the complete article.